uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC GlobeNewswire March 04, 2026 NEW YORK and NEW ORLEANS, March 03, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General […]